Induction of topoisomerase I cleavage complexes by 1-beta -D-arabinofuranosylcytosine (ara-C) in vitro and in ara-C-treated cells.
暂无分享,去创建一个
[1] Y. Pommier,et al. Poisoning of human DNA topoisomerase I by ecteinascidin 743, an anticancer drug that selectively alkylates DNA in the minor groove. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[2] Y. Pommier,et al. Induction of Reversible Complexes between Eukaryotic DNA Topoisomerase I and DNA-containing Oxidative Base Damages , 1999, The Journal of Biological Chemistry.
[3] Y. Pommier,et al. Induction of Topoisomerase I Cleavage Complexes by the Vinyl Chloride Adduct 1,N 6-Ethenoadenine* , 1998, The Journal of Biological Chemistry.
[4] Y. Pommier,et al. Mechanism of action of eukaryotic DNA topoisomerase I and drugs targeted to the enzyme. , 1998, Biochimica et biophysica acta.
[5] J N Weinstein,et al. Molecular modeling studies of the DNA-topoisomerase I ternary cleavable complex with camptothecin. , 1998, Journal of medicinal chemistry.
[6] W G Hol,et al. A model for the mechanism of human topoisomerase I. , 1998, Science.
[7] J. Champoux,et al. Crystal structures of human topoisomerase I in covalent and noncovalent complexes with DNA. , 1998, Science.
[8] S. Grant,et al. Ara-C: cellular and molecular pharmacology. , 1998, Advances in cancer research.
[9] Y. Pommier,et al. Trapping of Mammalian Topoisomerase I and Recombinations Induced by Damaged DNA Containing Nicks or Gaps , 1997, The Journal of Biological Chemistry.
[10] Y. Pommier,et al. Aclacinomycin A stabilizes topoisomerase I covalent complexes. , 1997, Cancer research.
[11] K. Kohn,et al. Effects of Uracil Incorporation, DNA Mismatches, and Abasic Sites on Cleavage and Religation Activities of Mammalian Topoisomerase I* , 1997, The Journal of Biological Chemistry.
[12] S. Morham,et al. Targeted disruption of the mouse topoisomerase I gene by camptothecin selection , 1996, Molecular and cellular biology.
[13] G. Ireton,et al. Biochemical and Biophysical Analyses of Recombinant Forms of Human Topoisomerase I (*) , 1996, The Journal of Biological Chemistry.
[14] S. Tornaletti,et al. Human DNA Topoisomerase I-mediated Cleavages Stimulated by Ultraviolet Light-induced DNA Damage (*) , 1996, The Journal of Biological Chemistry.
[15] Y. Pommier,et al. Eukaryotic DNA topoisomerases I. , 1995, Biochimica et biophysica acta.
[16] E. Kraut,et al. Analysis of topoisomerase I/DNA complexes in patients administered topotecan. , 1995, Cancer research.
[17] K. Gardner,et al. Solution structure of a DNA dodecamer containing the anti-neoplastic agent arabinosylcytosine: combined use of NMR, restrained molecular dynamics, and full relaxation matrix refinement. , 1994, Biochemistry.
[18] C. Moore,et al. Overexpression of human DNA topoisomerase I in insect cells using a baculovirus vector. , 1994, Protein expression and purification.
[19] A. Lu,et al. Mammalian topoisomerase I has base mismatch nicking activity. , 1994, The Journal of biological chemistry.
[20] K W Kohn,et al. Mechanisms of topoisomerase I inhibition by anticancer drugs. , 1994, Advances in pharmacology.
[21] A. Andersen,et al. Eukaryotic topoisomerase I-mediated cleavage requires bipartite DNA interaction. Cleavage of DNA substrates containing strand interruptions implicates a role for topoisomerase I in illegitimate recombination. , 1993, The Journal of biological chemistry.
[22] G. Hofmann,et al. In vitro and in vivo effects of clinically important camptothecin analogues on multidrug-resistant cells. , 1993, Oncology research.
[23] S. Shuman. Two classes of DNA end-joining reactions catalyzed by vaccinia topoisomerase I. , 1992, The Journal of biological chemistry.
[24] J. Svejstrup,et al. New technique for uncoupling the cleavage and religation reactions of eukaryotic topoisomerase I. The mode of action of camptothecin at a specific recognition site. , 1991, Journal of molecular biology.
[25] G. Hofmann,et al. Synergistic cell killing by ionizing radiation and topoisomerase I inhibitor topotecan (SK&F 104864). , 1991, Cancer research.
[26] G. A. van der Marel,et al. Molecular structure of a DNA decamber containing an anticancer nucleoside arabinosylcytosine: conformational perturbation by arabinosylcytosine in B-DNA. , 1991, Biochemistry.
[27] J. Champoux. 6 Mechanistic Aspects of Type-I Topoisomerases , 1990 .
[28] O. Westergaard,et al. A high affinity topoisomerase I binding sequence is clustered at DNAase I hypersensitive sites in tetrahymena R-chromatin , 1985, Cell.
[29] D. Kufe,et al. Relationships among Ara-CTP pools, formation of (Ara-C)DNA, and cytotoxicity of human leukemic cells. , 1984, Blood.
[30] J. Champoux. DNA is linked to the rat liver DNA nicking-closing enzyme by a phosphodiester bond to tyrosine. , 1981, The Journal of biological chemistry.
[31] D. Kufe,et al. Correlation of cytotoxicity with incorporation of ara-C into DNA. , 1980, The Journal of biological chemistry.
[32] J. Regan,et al. Inhibition of DNA excision repair in human cells by arabinofuranosyl cytosine: effect on normal and xeroderma pigmentosum cells. , 1979, Molecular pharmacology.
[33] S. Yoshida,et al. Inhibition of DNA polymerase-α and -β of calf thymus by 1-β-d-arabinofuranosylcytosine-5′-triphosphate , 1977 .
[34] N. Cozzarelli. The mechanism of action of inhibitors of DNA synthesis. , 1977, Annual review of biochemistry.
[35] G. Mueller,et al. Simple procedure for isolation of DNA, RNA and protein fractions from cultured animal cells. , 1975, Analytical biochemistry.
[36] F. Graham,et al. The Effect of 1-β-d-Arabinofuranosylcytosine on Growth, Viability, and DNA Synthesis of Mouse L-cells , 1970 .
[37] J. Furth,et al. Inhibition of Mammalian DNA Polymerase by the 5′-Triphosphate of 1-β-d-Arabinofuranosylcytosine and the 5′-Triphosphate of 9-β-d-Arabinofuranosyladenine , 1968 .